Scholarlink

Purpose <p>To investigate the spatial distribution of key malignant molecular markers in glioma using MRI-guided stereotactic biopsies for tissue validation.</p> Materials and methods <p>Thirty-seven patients with newly suspected gliomas underwent preoperative magnetic resonance imaging (MRI) followed by MRI-guided stereotactic biopsy and subsequent open craniotomy. Using preoperative MRI (T2-weighted imaging [T2WI]/fluid-attenuated inversion recovery [FLAIR] and contrast-enhanced T1WI), each tumor was radiologically subdivided into core, middle, and peripheral regions. Representative tissues from these regions were obtained via stereotactic biopsy. Immunohistochemistry (IHC) was performed to detect the expression of Ki67, ZEB1, NOTCH1, and HIF-1α.</p> Results <p>The expression levels of Ki67, ZEB1, NOTCH1, and HIF-1α were positively correlated with increasing glioma grade (Kruskal–Wallis test, all <i>P</i> &lt; 0.05).A significant spatial gradient was observed for Ki67 (<i>P</i> &lt; 0.001), ZEB1 (<i>P</i> &lt; 0.001), HIF-1α (<i>P</i> &lt; 0.001), and NOTCH1 (<i>P</i> = 0.001) expression across the core, middle, and peripheral regions (Friedman test). Post-hoc pairwise comparisons confirmed the most pronounced difference was between the core and periphery for all markers (all <i>P</i> &lt; 0.001).</p> Conclusions <p>The expression of Ki67, ZEB1, NOTCH1, and HIF-1α is closely associated with the malignant grade of gliomas and exhibits a conserved “core-to-periphery” decreasing gradient. The tumor core appears to be the molecular epicenter of aggressive phenotypes. These findings underscore the importance of targeting the radiologic core for diagnostic biopsy to avoid under-grading and suggest that spatial heterogeneity should be considered in therapeutic planning.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Spatial heterogeneity of malignant molecular markers in glioma revealed by stereotactic biopsy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月10日

查看全文
  • Caohang Qiu,
  • Kaixi Wei,
  • Chunhua Wang,
  • Celi Wang,
  • Yang Ming,
  • Lilei Peng,
  • Haiping He,
  • Shan Zeng

摘要

Purpose

To investigate the spatial distribution of key malignant molecular markers in glioma using MRI-guided stereotactic biopsies for tissue validation.

Materials and methods

Thirty-seven patients with newly suspected gliomas underwent preoperative magnetic resonance imaging (MRI) followed by MRI-guided stereotactic biopsy and subsequent open craniotomy. Using preoperative MRI (T2-weighted imaging [T2WI]/fluid-attenuated inversion recovery [FLAIR] and contrast-enhanced T1WI), each tumor was radiologically subdivided into core, middle, and peripheral regions. Representative tissues from these regions were obtained via stereotactic biopsy. Immunohistochemistry (IHC) was performed to detect the expression of Ki67, ZEB1, NOTCH1, and HIF-1α.

Results

The expression levels of Ki67, ZEB1, NOTCH1, and HIF-1α were positively correlated with increasing glioma grade (Kruskal–Wallis test, all P < 0.05).A significant spatial gradient was observed for Ki67 (P < 0.001), ZEB1 (P < 0.001), HIF-1α (P < 0.001), and NOTCH1 (P = 0.001) expression across the core, middle, and peripheral regions (Friedman test). Post-hoc pairwise comparisons confirmed the most pronounced difference was between the core and periphery for all markers (all P < 0.001).

Conclusions

The expression of Ki67, ZEB1, NOTCH1, and HIF-1α is closely associated with the malignant grade of gliomas and exhibits a conserved “core-to-periphery” decreasing gradient. The tumor core appears to be the molecular epicenter of aggressive phenotypes. These findings underscore the importance of targeting the radiologic core for diagnostic biopsy to avoid under-grading and suggest that spatial heterogeneity should be considered in therapeutic planning.